Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors

スポンサーリンク

概要

• 論文の詳細を見る
• 2011-11-10

著者

• Shiba T

  Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research

• Terui Shoji

  国立がんセンター中央病院

• Hatake Kiyohiko

  Department Of Medical Oncology Cancer Institute Hospital Of Japanese Foundation For Cancer Research

• Takahashi Shunji

  Cancer Inst. Hospital Tokyo Jpn

• Hatake Kiyohiko

  Division Of Medical Oncology Cancer Institute Hospital

• TAKAYAMA Shin

  Department of Surgery

• Ito Yoshinori

  Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research

• Shiba Tadayoshi

  Department Of Molecular Biology Kitasato University

• Hirata Kouichi

  First Department Of Surgery Sapporo Medical College

• Takahashi Shunji

  Department Of Oncology And Hematology Cancer Institute Hospital

• Okamoto Isamu

  The Department Of Respiratory Medicine Graduate School Of Medical Science Kumamoto University

• Matsushima Mieko

  Department Of Breast Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research

• Sakurai Takuma

  Division Of Clinical Chemotherapy Cancer Chemotherapy Center Japanese Foundation For Cancer Research

• Miyazato Masayo

  Department Of Breast Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research

• Hatake Kiyohiko

  Olympus Bio-imaging Laboratory The Cancer Chemotherapy Center Of The Jfcr

• Hatake Kiyohiko

  Department Of Medical Oncology Ariake Cancer Institute Hospital

• Miyazaki Masaki

  Department Of Medical Oncology Kinki University School Of Medicine

• Matsuura Masaaki

  Genome Center Japanese Foundation For Cancer Research

• Tsukahara Satomi

  Department Of Medical Oncology Cancer Institute Hospital Japanese Foundation For Cancer Research

• Tsukahara Satomi

  Department Of Medical Oncology The Cancer Institute Of Japanese Foundation For Cancer Research

• NAKAGAWA Kazuhiko

  Kinki University School of Medicine

• Makita Masujiro

  Genome Center Japanese Foundation For Cancer Research

• Seriu Taku

  Bristol-myers K.k

• TAKAHASHI Shunji

  The Cancer Institute Hospital of JFCR, Medical Oncology

• MIYAZAKI Masaki

  Kinki University Faculty of Medicine, Medical Oncology

• OKAMOTO Isamu

  Kinki University Faculty of Medicine, Medical Oncology

• ITO Yoshinori

  The Cancer Institute Hospital of JFCR, Medical Oncology

• UEDA Kyoji

  Bristol-Myers KK

• HATAKE Kiyohiko

  The Cancer Institute Hospital of JFCR, Medical Oncology

• Nakagawa Kazuhiko

  Kinki University Faculty Of Medicine Medical Oncology

• Ito Yoshinori

  Department Of Breast Oncology The Cancer Institute Hospital Of The Japanese Foundation For Cancer Research

• Okamoto Isamu

  Kinki University Faculty Of Medicine Medical Oncology

関連論文

• Cancer of Unknown Primary Site:A Review of 28 Cases and the Efficacy of Cisplatin/Docetaxel Therapy at a Single Institute in Japan
• Cross-sectional analysis of germline BRCA1 and BRCA2 mutations in Japanese patients suspected to have hereditary breast/ovarian cancer
• Primary Hepatic Low-Grade B-Cell Lymphoma of the Mucosa-Associated Lymphoid Tissue Type : A Case Report and Review of the Literature
• Histological Features of Breast Cancer, Highly Sensitive to Chemotherapy
• Increased incidence of interstitial pneumonia by CHOP combined with rituximab
• A Case of Acute Promyelocytic Leukemia during Gefitinib Treatment
• Functional MRI : Principles and Applications to the Visual System
• Allelic Loss at 1p34,13q12,17p13.3,and 17q21.1 Correlates With Poor Postoperative Prognosis in Breast Cancer
• Correlation of Allelic Loss with Poor Postoperative Survival in Breast Cancer
• PTEN/MMAC1 Mutations in Hepatocellular Carcinomas: Somatic Inactivation of Both Alleles in Tumors
• Efficacy of S-1 in heavily pretreated patients with metastatic breast cancer : cross-resistance to capecitabine
• Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients
• Does Lapatinib, a Small-Molecule Tyrosine Kinase Inhibitor, Constitute a Breakthrough in the Treatment of Breast Cancer?
• Efficacy and Safety of Combined Trastuzumab and Paclitaxel Therapy as a Second-Line Treatment in Women with Metastatic Breast Cancer : A Single Institutional Experience
• High Prevalence of HER-2/neu and p53 Overexpression in Inflammatory Breast Cancer
• Severe Infusion Reaction Induced by Trastuzumab : A Case Report
• Dose-finding phase I study of simultaneous weekly infusion with doxorubicin and docetaxel in patients with advanced breast cancer
• Pilot study of continuous low-dose 5-fluorouracil and cisplatin (FP regimen) for the treatment of metastatic breast cancer
• Expression profiling to predict postoperative prognosis for estrogen receptor-negative breast cancers by analysis of 25,344 genes on a cDNA microarray
• Amplification, up-regulation and over-expression of DVL-1, the human counterpart of the Drosophila disheveled gene, in primary breast cancers
• Nucleotide variations in genes encoding plasminogen activator inhibitor-2 and serine proteinase inhibitor B10 associated with prostate cancer
• Association of common missense changes in ELAC2 (HPC2) with prostate cancer in a Japanese case-control series
• High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families
• Multiplex Mutation Screening of the BRCA1 Gene in 1000 Japanese Breast Cancers
• Assessment of hormone receptor status in breast cancer
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in patients with advanced gastric cancer
• Absence of Gallium Uptake in Unicentric and Multicentric Castleman's Disease
• Next Generation Molecular Targeted Agents for Breast Cancer : Focus on EGFR and VEGFR Pathways
• Chemotherapy for Small-Bowel Adenocarcinoma at a Single Institution
• Autophagy and autophagic cell death are next targets for elimination of the resistance to tyrosine kinase inhibitors
• Modified irinotecan plus bolus 5-fluorouracil/L-leucovorin for metastatic colorectal cancer at a single institution in Japan
• Continuous treatment of bestatin induces anti-angiogenic property in endothelial cells
• Differential Regulation of Eotaxin-1/CCL11 and Eotaxin-3/CCL26 Production by the TNF-α and IL-4 Stimulated Human Lung Fibroblast(Pharmacology)
• Blockade of bulky lymphoma-associated CD55 expression by RNA interference overcomes resistance to complement-dependent cytotoxicity with rituximab
• Gene Therapy for Breast Cancer.-Review of Clinical Gene Therapy Trials for Breast Cancer and MDR1 Gene Therapy Trial in Cancer Institute Hospital
• No CD117 expression on B progenitors in the regenerating bone marrow
• Rare but important adverse effects of all-trans retinoic acid in acute promyelocytic leukemia and their management
• Philadelphia chromosome-negative cells with trisomy 8 after busulfan and interferon treatment of Ph^1-positive chronic myelogenous leukemia
• A survey of the timing and approach to the surgical management of patients with acute cholecystitis in Japanese hospitals
• Sentinel Lymph Node Biopsy Using Tin Colloid RI and Blue Dye Method
• Correlation of Allelic Losses and Clinicopathological Factors in 504 Primary Breast Cancers
• Surgery for Ductal Carcinoma in situ
• Tolerability and Safety of Classic Cyclophosphamide, Methotrexate, and Fluorouracil Treatment in Japanese Patients with Early Breast Cancer
• Intraductal Papilloma with Bloody Discharge from Montgomery's Areolar Tubercle Examined by Ductoscopy from the Areola
• Reviewing the definition of "elderly"
• Report from the second Japanese Urological Association-Japanese Society of Medical Oncology joint conference, 2007 : 'Diagnosis and treatment of urological malignant tumors : How can we promote subspecialists?'
• Association of single nucleotide polymorphisms in the promoter region of the pro-opiomelanocortin gene (POMC) with low bone mineral density in adult women
• Association of a single-nucleotide polymorphism in the promoter region of leukemia inhibitory factor receptor gene with low bone mineral density in adult women
• Association of genetic variation of the RIL gene, encoding a PDZ-LIM domain protein and localized in 5q31.1, with low bone mineral density in adult Japanese women
• Association of natural tooth loss with genetic variation at the human matrix Gla protein locus in elderly women
• Association of the -381T/C promoter variation of the brain natriuretic peptide gene with low bone-mineral density and rapid postmenopausal bone loss
• Thirteen single-nucleotide polymorphisms in the human osteopontin gene identified by sequencing of the entire gene in Japanese individuals
• Linkage disequilibrium and haplotype analysis among ten single-nucleotide polymorphisms of interleukin 11 identified by sequencing of the gene
• Expression of constitutively activated EGFRvlll in non-small cell lung cancer
• Diagnostic Mammography and Ultrasonography for Palpable and Nonpalpable Breast Cancer in Women Aged 30 to 39 Years
• Diagnostic Ultrasonography and Mammography for Invasive and Noninvasive Breast Cancer in Women Aged 30 to 39 Years
• Functional pathway characterized by gene expression analysis of supraclavicular lymph node metastasis-positive breast cancer
• Improved detection of axillary hot nodes in lymphoscintigraphy in breast cancer located in the upper lateral quadrant with additional projection imaging
• What is the Predictor for Invasion in Non-palpable Breast Cancer with Microcalcifications?
• Mammographic and Clinicopathological Features of Mucinous Carcinoma of the Breast
• A nucleotide variant in the promoter region of the interleukin-6 gene associated with decreased bone mineral density
• Linkage of interleukin 6 locus to human osteopenia by sibling pair analysis
• Association of bone mineral density with polymorphism of the human matrix Gla protein locus in elderly women
• Trends in the incidence of hip fracture in Japan,1987-1997:The third nationwide survey
• Stanniocalcin 2 overexpression in castration-resistant prostate cancer and aggressive prostate cancer
• Oncogenic role of NALP7 in testicular seminomas
• Prospective study of combined treatment with interferon-alpha and active vitamin D_3 for Japanese patients with metastatic renal cell carcinoma
• Novel single nucleotide polymorphisms of the human nuclear factor kappa-B 2 gene identified by sequencing the entire gene
• A Single Nucleotide Polymorphism in the Matrix Metalloproteinase-1 Promoter in Endometrial Carcinomas
• Lipomatous Hypertrophy of the Interatrial Septum With Cutaneous Lipomatosis
• Endoscopic Classification of Intraductal Lesions and Histological Diagnosis
• Histopathological Study of Local Residual Carcinoma After Simulated Lumpectomy
• Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells
• Overexpression of the potential kinase serine/threonine/tyrosine kinase 1 (STYK 1) in castration-resistant prostate cancer
• Possible use of combination chemotherapy with mitomycin C and methotrexate for metastatic breast cancer pretreated with anthracycline and taxanes
• Association of radial bone mineral density with CA repeat polymorphism at the interleukin 6 locus in postmenoposal Japanese women
• Complete Resection After Imatinib Treatment of a Gastrointestinal Stromal Tumor of the Ileum with Peritoneal Metastases : Report of a Case
• Synthesis and properties of N-substituted maleimides conjugated with 1,4-phenylene or 2,5-thienylene polymers
• Estrone and 17β-Estradiol Reverse Breast Cancer Resistance Protein-mediated Multidrug Resistance
• Identification and Characterization of a Deletion Mutant of DNA Topoisomerase I mRNA in a Camptothecin-resistant Subline of Human Colon Carcinoma
• Recent advances in ideas on the molecular pathology and clinical aspects of Von Hippel-Lindau disease
• Mutational Analysis of Mismatch Repair Genes, hMLH1 and hMSH2, in Sporadic Endometrial Carcinomas with Microsatellite Instability
• Retreatment of recurrent malignant pleural mesothelioma with cisplatin and pemetrexed
• Apocrine metaplasia of breast cancer : clinicopathological features and predicting response
• Phase I study of inotuzumab ozogamicin (CMC-544) in Japanese patients with follicular lymphoma pretreated with rituximab-based therapy
• Dlk-1, a cell surface antigen on foetal hepatic stem/progenitor cells, is expressed in hepatocellular, colon, pancreas and breast carcinomas at a high frequency
• Reoperative Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence After Previous Axillary Lymph Node Dissection : Report of a Case
• 5αDH-DOC (5α-dihydro-deoxycorticosterone) activates androgen receptor in castration-resistant prostate cancer
• Mutation analysis of the BRCA1 gene in 76 Japanese ovarian cancer patients : four germline mutations, but no evidence of somatic mutation
• Anal Canal Carcinoma with Pagetoid Spread : Report of a Case
• Estrogen-mediated post transcriptional down-regulation of P-glycoprotein in MDR1-transduced human breast cancer cells
• Circulating tumor cells as a surrogate marker for determining response to chemotherapy in Japanese patients with metastatic colorectal cancer
• Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
• Predictors of the Efficacy of FOLFIRI plus Bevacizumab as Second-Line Treatment in Metastatic Colorectal Cancer Patients
• Detection of circulating tumor cells in peripheral blood of heavily treated metastatic breast cancer patients
• Incidence of chemotherapy-induced amenorrhea in premenopausal patients with breast cancer following adjuvant anthracycline and taxane
• High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin
• Phase I study of dasatinib (BMS-354825) in Japanese patients with solid tumors
• Absence of Gallium Uptake in Unicentric and Multicentric Castleman's Disease
• 5. Tanstuzumab Treatment for Breast Cancer

もっと見る 閉じる

スポンサーリンク